Medicamen-Biotech-Ltd Stock/Share Prices, Buy and Sell Medicamen-Biotech-Ltd BSE Stocks – AxisDirect.

Market Snapshot

BSE Sensex: 36594.33 -0.39%
BSE 500: 13968.64 -0.42%
BSE 200: 4527.59 -0.43%
BSE 100: 10843.66 -0.41%
BSE Mid-Cap: 13396.83 -0.72%
BSE Small-Cap: 12803.78 -0.35%
BANKEX: 25347.89 -2.22%
BSE IT Sector: 15756.44 0.17%
Nifty 50: 10768.05 -0.42%
Nifty 500: 8813.95 -0.42%
Nifty 200: 5569 -0.43%
Nifty 100: 10919.7 -0.39%
Nifty Midcap 100: 15253.6 -0.71%
Nifty Small 100: 4870.25 -0.20%
Nifty IT: 15565.2 0.19%
Nifty PSU Bank: 1489.75 -2.67%

News:

Canara Bank board approves pla...
M&M Financial board to decide ...
RIL hits record high after fue...
SBI board to consider raising ...
Tata Motors posts 64% slump in...

Medicamen Biotech Ltd BSE
Pharmaceuticals, Small Cap

Invest

10 Jul 2020 | 03:59 PM

326.10

45.75 (16.32%)

Add to Watchlist

This awesome feature is still in our labs.
Set Alert

This awesome feature is still in our labs.

Underperforms Index

-21.97%

Return (1Y)

Underperformed S&P BSE Healthcare by 51.88%
More Volatile

3.87%

Standard Deviation (1Y)

Higher than S&P BSE Healthcare by 2.31%
Not so consistent

5/12

Months

underperformed S&P BSE Healthcare
AxisDirect View

No View

52 Week High-Low

447

153

News & Announcements

Board of Medicamen Biotech recommends final dividend
8 days ago

Board of Medicamen Biotech recommends final dividend

02 - Jul - 2020 12:00 AM | 8 days ago

Medicamen Biotech announced that the Board of Directors of the Company at its meeting held on 30 June 2020, inter alia, have recommended the final dividend of Rs 0.5 per equity Share (i.e. 5%) , subject to the approval of the shareholders.
Powered by Capital Market - Live News

Medicamen Biotech consolidated net profit rises 3.75% in the March 2020 quarter

10 days ago

Medicamen Biotech announces board meeting date
16 days ago

Medicamen Biotech announces board meeting date

24 - Jun - 2020 12:00 AM | 16 days ago

Medicamen Biotech will hold a meeting of the Board of Directors of the Company on 30 June 2020.
Powered by Capital Market - Live News
Medicamen Biotech standalone net profit rises 53.33% in the December 2019 quarter
154 days ago

Medicamen Biotech standalone net profit rises 53.33% in the December 2019 quarter

07 - Feb - 2020 12:00 AM | 154 days ago

Net profit of Medicamen Biotech rose 53.33% to Rs 3.68 crore in the quarter ended December 2019 as against Rs 2.40 crore during the previous quarter ended December 2018. Sales rose 46.72% to Rs 35.33 crore in the quarter ended December 2019 as against Rs 24.08 crore during the previous quarter ended December 2018.
Particulars Quarter Ended
Dec. 2019 Dec. 2018 % Var.
Sales 35.33 24.08 47
OPM % 15.40 18.15 -
PBDT 5.70 4.24 34
PBT 5.06 3.65 39
NP 3.68 2.40 53
Powered by Capital Market - Live News

Price vs Volume

1D
5D
1M
3M
1Y
3Y
5Y
MAX

Stock Trivia

Medicamen Biotech Ltd has topped the 5 years performance among stocks in Pharmaceuticals Sector
FII shareholding in Medicamen Biotech Ltd has decreased by -4.21% since past 1 Year

Peer Comparison on Risk - Return

Thanks for Liking, Please spread your love by sharing...

vV5.0.0.6-60